Skip to main content

Indian Journal of Hematology and Blood Transfusion

Ausgabe 4/2023

Inhalt (29 Artikel)

Open Access ORIGINAL ARTICLE

Clinical Relevance of Interferon Regulatory Family-4 (IRF4) Expression in Newly Diagnosed Patients with Multiple Myeloma

May E. Abdelmonem, Hend A. Nooh, Mona S. El Ashry

Open Access ORIGINAL ARTICLE

In-vitro Modulation of mTOR-HIF-1α Axis by TLR7/8 Agonist (Resiquimod) in B-Chronic Lymphocytic Leukemia

Rana M. Hanafy, Soheir R. Demian, Lobna A. Abou-Shamaa, O. Ghallab, Eman M. Osman

ORIGINAL ARTICLE

Depolarized Mitochondrial Membrane Potential and Elevated Calcium in Platelets of Sickle Cell Disease

Samarjit Maharana, Chitrali Laha Roy, Kamal Kishor, Ravi Ranjan, Firdos Ahmad, Manoranjan Mahapatra, Renu Saxena, Meganathan Kannan

ORIGINAL ARTICLE

Comparison of HbA2 Using High Performance Liquid Chromatography Versus Haemoglobin Capillary Zone Electrophoresis

Gurpreet Kaur, Seema Tyagi, Tulika Seth, Manoranjan Mahapatra, Ganesh Kumar Viswananthan, Jasmita Dass, Rama Hariharan, Arijit Sen

Open Access Original Article

Study of the Frequency and Specificity of Red Cell Antibodies in Patients with Hemoglobinopathies

Manal M. Wilson, Manal M. W. El Masry, Mona Kamal El-Ghamrawy, Nessma Abd El-Hadi, Amany A. Abou-Elalla

ORIGINAL ARTICLE

Preconditioning Modified-Easix as a Predictor of Prognosis in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Zeynep Arzu Yegin, Emine Merve Savaş, Şeyma Yıldız, Münevver İrem Kök, Meltem Büşra Erdemir, Başak Bostankolu Değirmenci, Zübeyde Nur Özkurt, Münci Yağcı

Open Access ORIGINAL ARTICLE

Effective and Elaborative Induction Program for Mitigating Myths and Misconceptions Linked to Hematopoietic Stem Cell Transplantation in a Resource Limited Setting

Safaa A. A. Khaled, Mahmoud M. Elzembely, Asmaa M. A. Soliman, Nahed Shwakat, Nashwa Rafaat, Mohamed A. Malek, Esmat S. Abdelmageed

Open Access Original Article

Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Hemophilia A in India

Nirmalkumar Choraria, Savita Rangarajan, M. Joseph John, Shashikant Apte, Pritam Gupta, Seema Pai, Rohit Chand, Shyam Parvatini, G. S. H. Ramakanth, Jeremy Rupon, Amit Chhabra, Hitesh Bhaskarrao Muley, Damien Simoneau

Open Access Original Article

Nonacog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Moderately Severe or Severe Hemophilia B in India

Nirmalkumar Choraria, Savita Rangarajan, M. Joseph John, Shashikant Apte, Pritam Gupta, Seema Pai, Rohit Chand, Shyam Parvatini, G. S. H. Ramakanth, Jeremy Rupon, Amit Chhabra, Hitesh Bhaskarrao Muley, Damien Simoneau

Open Access ORIGINAL ARTICLE

Cell Death Markers in Children with Immune Thrombocytopenic Purpura: A Preliminary Study

Sohier Yahia, Waleed Eldars, Heba Eldegla, Ahmed K. Mansour, Mouna Guaida, Mohamed S. A. Abdelkader, Yahya Wahba

ORIGINAL ARTICLE

Incidence and Management of Thromboembolism in Patients with Acute Leukemia

Salih Güler, Aytül Temuroğlu, Melike Sezgin Evim, Adalet Meral Günes

ORIGINAL ARTICLE

Thyroid Dysfunction in Patients with and Without Venous Thromboembolism: a Case Control Study

Rizwana Naushad, Jayachandran selvaraj, Jayaprakash Sahoo, Stalin Viswanathan, Rajeswari Murugesan

ORIGINAL ARTICLE

Investigating the Correlation Between HLA-II Gene Polymorphism and RhE Alloimmunization in Pregnant Chinese Women

Wenling Shang, Guojin Ou, Xin Ji, Jian Chen, Jue Wang, Yongmei Jiang

ORIGINAL ARTICLE

High Autophagy Patterns in Swelling Platelets During Apheresis Platelet Storage

Lu Yu, Shifang Yu, Yunlei He, Gang Deng, Qiang Li

SHORT COMMUNICATION

Salvage Using Polatuzumab Vedotin Based Therapy in Relapsed Refractory Large B-Cell Lymphomas: Early Experience from a Real-World Middle-Income Setting Using Named-Patient Compassionate Access Program

V. S. Radhakrishnan, R. Pincha, V. Raina, J. K. Garg, A. Nag, S. J. Bhave, R. Achari, D. Dey, I. Arun, Z. Lateef, S. S. Vinarkar, M. Parihar, S. Sen, D. K. Mishra, M. Chandy, R. Nair

Short Communication

Evaluation of Diagnostic Usefulness of CD200 Expression in B-cell Chronic Lymphoproliferative Disorders

Abhishek Purohit, Manali Satiza, Venkatesan Somasundaram, Rahul Sharma, Pravas Mishra, Tulika Seth, Seema Tyagi, Manoranjan Mahapatra, Hara Prasad Pati, Renu Saxena

SHORT COMMUNICATION

Biclonal Low-Grade B Cell Lymphoma as Detected by Multiparametric Flow Cytometry in Blood and Marrow

Thulasi Raman Ramalingam, Srikanth Muralikrishnan, Jose Easow, Lakshman Vaidhyanathan

Correspondence

Co-inherited α-Globin Gene Cluster Duplication Compromises RBC Indices-Based Thalassemia Screening

Huan-Qing Chen, Li-Sha Wu, Fan Jiang, Dong-Zhi Li

CORRESPONDENCE

Chronic Kidney Disease has a Higher Prevalence in Polycythemia Vera than in Secondary Polycythemia, a Matched Case–Control Analysis

Ivan Krečak, Hrvoje Holik, Martina Morić Perić, Ivan Zekanović, Božena Coha, Marko Lucijanić

CORRESPONDENCE

A Potential Novel Entity for Polycythemia Vera: JAK2 Exon 24 Mutation

Atakan Turgutkaya, Ali Zahit Bolaman, İrfan Yavaşoğlu

CORRESPONDENCE

Analysis of an Inherited FXII Deficiency Pedigree Associated with Double Heterozygous Mutations in the F12 Gene

Manlin Zeng, Kaiqi Jia, Haixiao Xie, Yaosheng Xie, Lihong Yang, Yuan Chen, Yanhui Jin, Mingshan Wang

IMAGES

Castleman Disease Variant of Poems Syndrome Complicated with Multiple Osteosclerotic Lesions

Manaswinee Mallik, Lakshmon Kalikkaleth, Naresh Kumar Chirumamilla, Arihant Jain, Charanpreet Singh, Aditya Jandial, Amanjit Bal, Deepesh Lad, Alka Khadwal, Pankaj Malhotra, Gaurav Prakash

IMAGES

Conventional Gold Standard Techniques: Indeed a Saviour in the Era of Automation!!

Yashaswi Dhiman, Manish Raturi, Bhawana Adhikari, Himanshu Rawat, Dushyant Singh Gaur

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.